Javascript must be enabled to continue!
Assessment of The Risk Factors for Statin-Related Myopathy in the Indian Population
View through CrossRef
Statins are widely used hypolipidemic drugs with limitations due to myopathy. Several comorbid factors act as predisposing factors for statin-related myopathy (SRM) and are rarely studied in the Indian population. In this study, we aim to understand the various risk factors involved in the occurrence of SRM, which may give insight towards the management of statin intolerance. A cross-sectional and non-interventional clinical study with 700 subjects, both statin and non-statin users, was conducted. Subjects were enrolled after ethical approval and informed consent. Information on case report forms and blood samples for clinical chemistry investigations were collected. SPSS version 21 was used to collect and analyze data. Based on statistical analysis, we found myopathy in statin users (19%), nonstatin users (11%), and total subjects (16%), respectively. No significant association of myopathy was observed with the female sex, differences in food habits, physical activity, alcohol intake, or comorbid factors like diabetes and hypertension. Smoking is associated with myopathy in pooled subjects, whereas age (>60) is associated with myopathy in statin users. Slight differences in mean values of bilirubin and alanine transferase were observed between myopathic and non-myopathic subjects. Therefore, the study demonstrates that smoking is related to myopathy regardless of statin usage. Statin users over 60 were shown to be at a greater risk for myopathy than non-statin users.
Lapin Press Publications (LPP)
Title: Assessment of The Risk Factors for Statin-Related Myopathy in the Indian Population
Description:
Statins are widely used hypolipidemic drugs with limitations due to myopathy.
Several comorbid factors act as predisposing factors for statin-related myopathy (SRM) and are rarely studied in the Indian population.
In this study, we aim to understand the various risk factors involved in the occurrence of SRM, which may give insight towards the management of statin intolerance.
A cross-sectional and non-interventional clinical study with 700 subjects, both statin and non-statin users, was conducted.
Subjects were enrolled after ethical approval and informed consent.
Information on case report forms and blood samples for clinical chemistry investigations were collected.
SPSS version 21 was used to collect and analyze data.
Based on statistical analysis, we found myopathy in statin users (19%), nonstatin users (11%), and total subjects (16%), respectively.
No significant association of myopathy was observed with the female sex, differences in food habits, physical activity, alcohol intake, or comorbid factors like diabetes and hypertension.
Smoking is associated with myopathy in pooled subjects, whereas age (>60) is associated with myopathy in statin users.
Slight differences in mean values of bilirubin and alanine transferase were observed between myopathic and non-myopathic subjects.
Therefore, the study demonstrates that smoking is related to myopathy regardless of statin usage.
Statin users over 60 were shown to be at a greater risk for myopathy than non-statin users.
.
Related Results
Investigation of the Statin Paradox in Different Populations of VICs
Investigation of the Statin Paradox in Different Populations of VICs
AbstractWhile numerous clinical studies have examined the effect of HMG-CoA reductase inhibitors (statin drugs) on calcific aortic valve disease (CAVD), their conflicting results h...
Does Preoperative Statin Exposure Reduce Prosthetic Joint Infections and Revisions Following Total Joint Arthroplasty?
Does Preoperative Statin Exposure Reduce Prosthetic Joint Infections and Revisions Following Total Joint Arthroplasty?
Introduction: The pleiotropic effects of statins extend beyond managing cardiovascular health and are suggested to modulate Staphylococcus aureus biofilm formation with prosthetic ...
Atheroma Progression in Hyporesponders to Statin Therapy
Atheroma Progression in Hyporesponders to Statin Therapy
Objective—
Lowering low-density lipoprotein cholesterol (LDL-C) with statins has been demonstrated to slow plaque progression. This antiatherosclerotic effect in patien...
Statin use and myopathy. Not always guilty
Statin use and myopathy. Not always guilty
Abstract
Objectives
Statins are the cornerstone of the treatment and prevention of cardiovascular disease but have been associat...
Creatine for Prevention of Statin Myopathy
Creatine for Prevention of Statin Myopathy
Statins prevent cardiovascular diseases, yet their use is limited by the muscle disturbances they cause. Rarely, statin-induced myopathy is autoimmune, but more commonly it is due ...
Statins do not prevent acute organ failure in ventilated ICU patients: single-centre retrospective cohort study
Statins do not prevent acute organ failure in ventilated ICU patients: single-centre retrospective cohort study
Abstract
Introduction
Observational studies suggest statin therapy reduces incident sepsis, but few studies have examined the impact...
Statin Use and Its Effects on Skeletal Related Events in Patients with Multiple Myeloma
Statin Use and Its Effects on Skeletal Related Events in Patients with Multiple Myeloma
Abstract
Introduction: Skeletal related events (SRE) in multiple myeloma (MM) patients are associated with significant morbidity and mortality. Studies assessing the...
Secondary prevention in young patients after acute ST segment elevation myocardial infarction: missing the goals and suffering the penalties
Secondary prevention in young patients after acute ST segment elevation myocardial infarction: missing the goals and suffering the penalties
Abstract
Introduction
Young patients that suffer an acute ST segment elevation myocardial infarction (STEMI) are an especially v...


